天美传媒

The lab of Evan Snyder, M.D. Ph.D. at Sanford Burnham Prebys Medical Discovery Institute, is at the forefront of stem cell research,  investigating how neural stem cells can be used to treat diseases like Parkinson鈥檚 disease & Bipolar disorder.

Jeffrey Shaman, PhD, MS, is the Chief Science Officer at Coriell Life Sciences where he oversees the company鈥檚 research, education, and clinical programs and leads efforts focused on bridging the gap between genetic science and clinical application.  Dr. Shaman brings years of experience in advising cross-functional teams together with his scholarship in genetics, pharmacology, stem cells, and clinical laboratory operations.  Along with the CEO, he forges strategic partnerships with worldwide companies, laboratories, academic institutions, public/private self-insured companies, and federal, state, and regional healthcare and employee systems.

Dr. Shaman supports a team of scientists dedicated to precision medicine and who actively research, publish, and present findings in top-tier peer-reviewed journals. He is passionate about educating people from all backgrounds about the power of genetics and pharmacogenomic testing that is integrated with patient health history and clinical decision-support to proactively promote better health.

Dr. Shaman holds a doctoral degree from The Johns Hopkins University School of Medicine in Pharmacology and Molecular Sciences, where his research centered on DNA, epigenetics, and nuclear structure and function. He earned his Master of Science degree from The University of Medicine and Dentistry of New Jersey in Cell & Developmental Biology.  Dr. Shaman held a faculty position at the University of Hawai鈥榠 Institute of Biogenesis Research before serving a fellowship at Harvard Medical School and implementing a translational research program at Beth Israel Deaconess Medical Center and the Bedford Stem Cell Research Foundation.

Dr Coopman鈥檚 research focuses on how we can manufacture cell-based therapies for regenerative medicine.

She is particularly interested in developing scalable systems for stem cell growth and improving methods of cell preservation so that we can produce clinically relevant numbers of cells that are also effective and safe.

 is a tireless advocate for using embryo technologies to improve genetics of livestock and reduce food insecurity throughout the world. He is advancing technology in both livestock production and human medicine through his research on embryo/developmental biology, stem cells, cloning, transgenic livestock, reproduction, genomics, and regenerative biology.
More information: Wheeler's research activities can be divided into six areas of research. Generally, the work can be described as large animal reproductive physiology with an emphasis on 1) production of transgenic livestock, particularly swine and cattle, with improved production characteristics; 2) molecular and cellular mechanisms involved in embryonic cell development/differentiation and early embryonic gene expression; 3) genetic evaluation, molecular gene mapping in livestock, early embryonic genotype evaluation; 4) development of remote sensing and microfludic handling methods for mammalian embryos; 5) the use of stem cells (adult and embryonic) for tissue engineering and cell-base therapies; and 6) the use assisted reproductive technologies (in vitro maturation, in vitro fertilization, embryo culture, non-invasive embryo evaluation and embryo transfer) to improve livestock and food production. His team's long term goals are to 1) identify genes that regulate reproduction, lactation and growth; 2) develop methodologies in embryos to edit, transfer and utilize these genes for the genetic improvement of livestock; and 3) devise strategies for using stem cells for cell and tissue replacement.
Affiliations: Wheeler is a professor in the  in the  (ACES) at the . He is also affiliated with the  and the  at Illinois.